TuHURA Biosciences adopts inducement equity plan, adds detail in amended filing

TuHURA Biosciences, Inc. disclosed in an 8-K filed September 16, 2026 that its board of directors adopted the TuHURA Biosciences, Inc. 2026 Inducement Equity Incentive Plan on September 10, 2026, under which the company may from time to time grant equity awards to new employees as a material inducement to their entering into employment with the company or one of its subsidiaries.¹

The plan was adopted without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4) and will be administered by the Compensation Committee of the Board¹. The board reserved 5,000,000 shares of the company's common stock, par value $0.001 per share, for issuance under the Inducement Plan¹. The only persons eligible to receive awards under the Inducement Plan are individuals who satisfy the standard for inducement grants under the Nasdaq Rule.¹

Award types are broad: nonqualified stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance shares, performance units and other stock-based awards; no incentive stock options may be granted under the Inducement Plan.¹ Grant authority is limited under Nasdaq rules, restricted to the Compensation Committee, provided that it is comprised solely of independent directors, or a majority of the company's independent directors.¹

An 8-K/A filed September 17, 2026 amended the original report to add detail to Item 5.02. It confirmed that the company has not yet, as of the date of the adoption of the Inducement Plan, granted any equity awards under the Inducement Plan², and that all grants of equity awards made under the Inducement Plan will be announced by the company in a press release in accordance with the requirements of the Nasdaq Rule.²

The amendment also stated that the board currently expects that all equity awards granted under the Inducement Plan will be granted in the form of stock option grants to new employees that will have an exercise price equal to or greater than the closing price of the company's common stock on the date of grant.² Additionally, the shares reserved for issuance under the Inducement Plan will not become issued and outstanding unless and until the stock options issued under the Inducement Plan to new employees become vested and are exercised.²